BAP1 and neoplasm: Among their two primary therapeutic mechanisms, the potential of OVs to inhibit the protein synthesis in tumor cells and destroy infected tumor cells by self-replication is the most probable mechanism underlying the superior efficacy of JX-594 in the reduction of BAP1-mutant tumors [4].